---
document_datetime: 2023-09-21 19:57:26
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/numient-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: numient-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.8288962
conversion_datetime: 2025-12-14 14:32:20.383695
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Numient

Procedural steps taken and scientific information after the authorisation

<!-- image -->

<!-- image -->

| Application number   | Scope                                                                                                                                                                                                  | Opinion/ Notification 1 issued on product   | Commission Decision Issued 2 / amended on no   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|------------------------------------------------|----------------------------------|-----------|
| T/0005               | Transfer of Marketing Authorisation                                                                                                                                                                    | 24/07/2018                                  | 03/08/2018                                     | SmPC, Labelling and PL           |           |
| IB/0004/G            | This was an application for a group of variations. B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data) Medicinal | 09/10/2017                                  | 03/08/2018                                     | SmPC, Labelling and PL           |           |

Medicinal product no longer authorised

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3 SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | B.II.f.1.b.2 - Stability of FP - Extension of the shelf life of the finished product - After first opening (supported by real time data)   |            |               | authorised                        |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------|------------|---------------|-----------------------------------|
| PSUSA/10479 /201611 | Periodic Safety Update EU Single assessment - carbidopa / levodopa (for centrally authorised product)                                      | 09/06/2017 | n/a           | PRAC Recommendation - maintenance |
| PSUSA/10479 /201605 | Periodic Safety Update EU Single assessment - carbidopa / levodopa (for centrally authorised product)                                      | 01/12/2016 | n/a           | PRAC Recommendation - maintenance |
| T/0002              | Transfer of Marketing Authorisation                                                                                                        | 18/10/2016 | 14/11/2016 no | SmPC, Labelling and longer        |

Medicinal product no longer authorised